# Evaluation of Safety and Performance of the EyenableTM Intraocular Lens for Cataract Treatment

> **NCT06223113** · NA · UNKNOWN · sponsor: **Xi'an Eyedeal Medical Technology Co., Ltd** · enrollment: 200 (estimated)

## Conditions studied

- Cataract

## Interventions

- **DEVICE:** EyenableTM PA60AS1 IOL

## Key facts

- **NCT ID:** NCT06223113
- **Lead sponsor:** Xi'an Eyedeal Medical Technology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02
- **Primary completion:** 2025-02
- **Final completion:** 2025-02
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06223113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06223113, "Evaluation of Safety and Performance of the EyenableTM Intraocular Lens for Cataract Treatment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06223113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*